StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Heron Therapeutics (HRTX) PT Raised to $51 at Jefferies
June 21, 2018 11:39 AM
Jefferies raised its price ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
Heron Therapeutics (HRTX) PT Raised to $80 at Evercore ISI
June 22, 2018 8:33 AM
Heron Therapeutics (HRTX) PT Raised to $44 at BofA/Merrill Lynch
June 22, 2018 6:31 AM
Heron Therapeutics (HRTX) PT Raised to $46 at Leerink Partners; 'Focus Moving to HTX-011's Commercialization'
June 22, 2018 6:12 AM
Heron Therapeutics (HRTX) PT Raised to $50 at Oppenheimer
June 22, 2018 1:41 AM
Heron Therapeutics (HRTX) PT Raised to $41 at Mizuho Securities
June 22, 2018 1:38 AM
Heron Therapeutics (HRTX) PT Raised to $66 at Needham & Company
June 21, 2018 3:48 PM
Heron Therapeutics (HRTX) PT Raised to $54 at Cowen; Sees HTX-011 as $1B+ Opportunity
June 21, 2018 1:15 PM
Two More Positive HTX-011 Studies Supports Bullish Heron Therapeutics (HRTX) Thesis - Cantor Fitzgerald
June 21, 2018 10:47 AM
Heron Therapeutics (HRTX) PT Raised to 'Street High' $80 at Evercore ISI
June 21, 2018 10:23 AM
Pre-Open Movers 06/21: (CASI) (HRTX) (DRI) (KR) Higher; (VERI) (LMNR) (AOBC) Lower (more...)
June 21, 2018 9:27 AM
Form 8-K HERON THERAPEUTICS, INC. For: Jun 21
June 21, 2018 8:12 AM
Heron Therapeutics (HRTX) Says HTX-011 for Postoperative Pain Management Receives Breakthrough Therapy Designation from FDA
June 21, 2018 8:05 AM
HTX-011 for Postoperative Pain Management Receives Breakthrough Therapy Designation from FDA
June 21, 2018 8:05 AM
